The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Home
>
Maryland
>
Rockville
>
Bioqual Inc

Bioqual Inc

  • Contact Person: Mitchell Franklin
  • Contact Phone: 240-404-7654
  • Contact Email: mfranklin@bioqual.com
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • For Profit Organization
  • Industries Served:
  • Product Areas: OTHER MEDICAL SERVICES, MEDICAL- OTHER

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $838,971 - Monday the 5th of November 2012
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    NON-HUMAN PRIMATE MODEL FOR FILOVIRUS VACCINE EFFICACY TESTING. 11/14/2011 - 11/30/2013. EXERCISE OPTIONS 1, 2, AND 3.C14
  • $3,500 - Friday the 8th of August 2014
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    TAS::75 0885 RECOVERY ACT NHP BLOOD FROM SIV+ RHESUS MACAQUES BRDU TREATED
  • $323,382 - Monday the 5th of November 2012
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    NON-HUMAN PRIMATE MODEL FOR FILOVIRUS VACCINE EFFICACY TESTING
  • $259,500 - Wednesday the 1st of June 2016
    Food And Drug Administration
    DEPT OF HHS/FOOD AND DRUG ADMINISTRATION
    IGF::CL::IGF CLOSELY ASSOCIATED - STUDY ON FLU-INFECTED FERRETS
  • $23,790 - Saturday the 1st of December 2012
    National Institutes Of Health
    NIH, NIAID DEA OA OFC ACQUISITIONS
    IGF::OT::IGF OTHER FUNCTIONS:IN VITRO ASSESSMENT FOR ANTIMICROBIAL ACTIVITY.
  • $23,100 - Thursday the 30th of January 2014
    Food And Drug Administration
    DEPT OF HHS/FOOD AND DRUG ADMINISTRATION
    "OTHER FUNCTION" - IGF::OT::IGF FERRET STUDY.
  • $20,945 - Wednesday the 15th of January 2014
    Food And Drug Administration
    DEPT OF HHS/FOOD AND DRUG ADMINISTRATION
    IGF::OT::IGF "OTHER FUNCTION" RNA SAMPLE PANEL FOR H5N1 VIRUS AND ANTIBODY ASSAY VALIDATION IN FERRETS.

© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.